Form 4: Atara Biotherapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
AnhCo Nguyen, EVP, Chief Sci. & Tech Officer of Atara Biotherapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 4, 2024, AnhCo Nguyen, EVP, Chief Sci. & Tech Officer of Atara Biotherapeutics, sold 10,746 shares of common stock at a price of $0.72.
- The sale was executed to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Nguyen directly owns 941,397 shares of Atara Biotherapeutics.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, such as officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of stock sale transaction. |
| 03/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.